American Healthcare REIT, Inc. (AHR)
| Market Cap | 9.05B +62.8% |
| Revenue (ttm) | 2.37B +12.7% |
| Net Income | 100.32M |
| EPS | 0.58 |
| Shares Out | 194.66M |
| PE Ratio | 80.73 |
| Forward PE | 72.34 |
| Dividend | $1.00 (2.15%) |
| Ex-Dividend Date | Mar 31, 2026 |
| Volume | 3,008,110 |
| Open | 46.54 |
| Previous Close | 46.81 |
| Day's Range | 46.24 - 47.51 |
| 52-Week Range | 34.86 - 54.67 |
| Beta | 0.80 |
| Analysts | Buy |
| Price Target | 58.85 (+26.64%) |
| Earnings Date | May 7, 2026 |
About AHR
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for AHR stock is "Buy." The 12-month stock price target is $58.85, which is an increase of 26.64% from the latest price.
News
American Healthcare REIT Transcript: Nareit REITweek: 2026 Investor Conference
Capital allocation is focused on managed care through SHOP and Trilogy, driving rapid NOI growth and industry-leading FFO per share increases. The investment pipeline exceeds $1 billion, with expansion centered on high-quality operators and innovative revenue management. Leadership succession is well planned, ensuring stability.
American Healthcare REIT to Present at Nareit's REITweek: 2026 Investor Conference
IRVINE, Calif.--(BUSINESS WIRE)-- #CFO--American Healthcare REIT, Inc. (NYSE: AHR) announced today that Chairman and Interim Chief Executive Officer, Jeff Hanson, Chief Financial Officer, Brian Peay, ...
American Healthcare REIT price target raised to $58 from $55 at KeyBanc
KeyBanc raised the firm’s price target on American Healthcare REIT (AHR) to $58 from $55 and keeps an Overweight rating on the shares. The firm continues to view American Healthcare…
American Healthcare REIT price target raised to $56 from $54 at RBC Capital
RBC Capital analyst Michael Carroll raised the firm’s price target on American Healthcare REIT (AHR) to $56 from $54 and keeps an Outperform rating on the shares. The company delivered…
American Healthcare REIT price target raised to $67 from $63 at BofA
BofA raised the firm’s price target on American Healthcare REIT (AHR) to $67 from $63 and keeps a Buy rating on the shares. The firm updated its price targets on…
American Healthcare REIT 14M share Spot Secondary priced at $50.40
The deal priced below last closing price of $51.68. BofA is acting as sole book running manager for the offering.
American Healthcare REIT Announces Pricing of Public Offering of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)-- #BofA--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today the pricing of an underwritten public offering of 14,000,000 shares of its common sto...
American Healthcare REIT 14M share Spot Secondary; price range $50.13-$51.68
BofA is acting as sole book running manager for the offering.
American Healthcare REIT announces offering of 14M shares of common stock
American Healthcare REIT (AHR) announced that it has commenced an underwritten public offering of 14M shares of its common stock. BofA Securities is acting as the underwriter for the offering.
American Healthcare REIT Announces Public Offering of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)-- #california--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today that it has commenced an underwritten public offering of 14,000,000 shares of i...
American Healthcare REIT Earnings Call Transcript: Q1 2026
Q1 2026 saw robust double-digit NOI growth, improved leverage, and raised full-year guidance, driven by strong segment performance and disciplined capital deployment. The acquisition pipeline remains active, with continued focus on high-quality operator partnerships.
American Healthcare REIT Earnings release: Q1 2026
American Healthcare REIT released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
American Healthcare REIT Slides: Q1 2026
American Healthcare REIT has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
American Healthcare REIT Quarterly report: Q1 2026
American Healthcare REIT has published its Q1 2026 quarterly earnings report on May 8, 2026.
American Healthcare REIT reports Q1 normalized FFO 50c, consensus 47c
Reports Q1 revenue $650.77M, consensus $687.04M. “Our first quarter results reflect another exceptionally strong period across our core metrics, including our ninth consecutive quarter of double-digit...
American Healthcare REIT raises 2026 normalized FFO view to $2.03-$2.09
Had previously seen 2026 normalized FFO $1.99-$2.05, consensus $2.01.
American Healthcare REIT Announces First Quarter 2026 Results; Increases Full Year 2026 Guidance
IRVINE, Calif., May 7, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) (the "Company," "we," "our," or "AHR") is announcing today its first quarter 2026 results and increasing full yea...
American Healthcare REIT Proxy statement: Proxy filing
American Healthcare REIT filed a proxy statement on April 9, 2026, providing details for shareholder voting and corporate governance matters.
American Healthcare REIT Announces Dates for First Quarter 2026 Earnings Release and Conference Call
IRVINE, Calif., April 7, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company") (NYSE: AHR) announced today that it will issue its first quarter 2026 earnings release on Thursday, May 7, ...
American Healthcare REIT Declares First Quarter 2026 Distribution
IRVINE, Calif., March 18, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the q...
American Healthcare REIT price target raised to $57 from $52 at Truist
Truist analyst Michael Lewis raised the firm’s price target on American Healthcare REIT (AHR) to $57 from $52 and keeps a Buy rating on the shares. The firm is positive…
American Healthcare REIT price target raised to $59 from $55 at Scotiabank
Scotiabank raised the firm’s price target on American Healthcare REIT (AHR) to $59 from $55 and keeps an Outperform rating on the shares. The firm notes the trilogy platform remains…
American Healthcare REIT Transcript: Citi’s Miami Global Property CEO Conference 2026
Senior housing and long-term care segments are benefiting from strong demographic-driven demand, limited new supply, and robust earnings growth. Operator alignment, technology adoption, and a focus on higher-reimbursement resident mix are driving performance, while new development is expected to remain limited until at least 2027.
American Healthcare REIT price target raised to $60 from $58 at UBS
UBS raised the firm’s price target on American Healthcare REIT (AHR) to $60 from $58 and keeps a Buy rating on the shares.
American Healthcare REIT price target raised to $55 from $52 at Citi
Citi raised the firm’s price target on American Healthcare REIT (AHR) to $55 from $52 and keeps a Neutral rating on the shares.